Kidney cancer is a commonly diagnosed cancer in adults, and clear cell renal cell carcinoma (ccRCC) is the most common histological subtype. Immune checkpoint inhibitors have revolutionized care for ...

Natural killer (NK) cells are innate immune lymphocytes that play a crucial role in tumor surveillance and control. In recent years, NK cell-based therapies for cancer have garnered significant ...

Neuroendocrine prostate cancer (NEPC) is rare at the time of initial diagnosis but much more common in patients treated with the combination of androgen deprivation therapy (ADT) and androgen receptor ...

Radical cystectomy is an effective treatment option for high-risk, non-muscle-invasive bladder cancer (NMIBC) to prevent progression. A recent 12-year multicenter study evaluated survival outcomes of ...

Although diagnostic efficacy of multiparametric magnetic resonance imaging (MRI) in identifying index lesions (ILs) in prostate cancer (PCa) patients is well established, challenges arise when ...

Urothelial carcinoma (UC) is the most common form of bladder cancer, accounting for nearly 90% of cases globally. 1 While earlier diagnoses have improved overall survival rates in recent years, the ...

Both males and females can be effected by stress urinary incontinence (SUI), with symptoms ranging from mild to severe. External urinary devices (EUDs) can help in managing incontinence in daily life ...

Renal cell carcinoma (RCC) patients in clinical T1 RCC generally exhibit a favorable prognosis. Guidelines recommend partial nephrectomy (PN), also for cT1b RCCs. Despite a favorable prognosis, there ...

Prostate cancer (PCa) remains the most common non-cutaneous cancer among men in Europe, with treatment advances improving mortality outcomes. Radical prostatectomy (RP) is a key treatment option for ...

Indwelling urinary catheters are often inserted and retained without appropriate indications in the inpatient setting, leading to catheter-associated urinary tract infections (CAUTIs). Previous ...

to evaluate the impact of Indwelling Urinary Catheters (IUC) on perioperative and functional outcomes, as well as the safety profile, of High-Power HoLEP for the treatment of prostate gland volumes ...

Metastatic penile cancer (PC) continues to have a poor prognosis due to inadequate treatment options. Enfortumab vedotin (EV) and sacituzumab govitecan (SG) are antibody-drug conjugates (ADCs) that ...